Skip to main content
AmigoFish

🧬 Choosing Conviction Over Convention in Biotech | David Li Rerelease (2/4)

From The Biotech Startups Podcast · · 25 min

This plays from the publisher's own server. We do not host a copy.

Open at the source

Not rated yet

Description

🧬 The Biotech Startups Podcast is powered by Excedr: helping life science startups accelerate R&D and commercialization with founder-friendly equipment leasing. Skip the upfront costs, stay lean, and focus on breakthrough science.

As a TBSP listener, you can get exclusive perks through Excedr's partner network: special savings, promotions, and more. Explore these offers today: https://www.excedr.com/partners.

“I think having that internal conviction is everything.”

In this part of the podcast, David Li reflects on leaving finance after realizing that an investing career would not give him the tangible impact he wanted. He explains what KKR taught him about business and patient needs, then describes the team-and-market test that led him to Benchling.

David also discusses the timing behind Benchling’s growth, the rise of new cell and gene therapy workflows, and the luck involved in joining a company at the right moment. He shares what it meant to build sales, marketing, customer success, and culture from the ground up.

He then looks back on the early-stage lessons that shaped his next move toward more directly patient-facing life science work, including the importance of conviction, strong teams, and seeing what winning looks like.

Key Topics Covered:

- Long-term career decision-making

- Patient impact in life sciences

- Evaluating early-stage teams and markets

- Benchling’s life science informatics platform

- Cell and gene therapy market timing

- Luck, conviction, and career risk

- Building early-stage teams

- Sales and go-to-market in biotech software

- Everest Detection and cancer early detection

If you enjoy The Biotech Startups Podcast, please consider subscribing, leaving a review, or sharing it with your friends. Thanks for listening.

Subscribe to the Podcast:

Apple: https://podcasts.apple.com/us/podcast/the-biotech-startups-podcast/id1679591994

Spotify: https://open.spotify.com/show/2PSL162R2s0zOwU5913Zv4

YouTube: https://www.youtube.com/@thebiotechstartupspodcast

Website: https://www.thebiotechstartupspodcast.com/?utm_source=podcast&utm_medium=show-notes&utm_campaign=the-biotech-startups-podcast-ep265

Find our guest, David Li, at these links:

LinkedIn: https://www.linkedin.com/in/david-li-9aa210b

Website: https://www.melioratherapeutics.com/

Find our host, Jon Chee, at these links:

LinkedIn: https://www.linkedin.com/in/jonchee/

Learn more about Excedr:

LinkedIn: https://www.linkedin.com/company/excedr/

Website: https://www.excedr.com

Intro & Outro Songs Created by OkKyojin, Owned by Excedr:

Website: https://flow.page/kyojin

Resources & Articles:

Benchling Online Lab Notebook: https://www.benchling.com/notebook

Benchling at MIT News: https://news.mit.edu/2016/benchling-google-docs-life-sciences-managing-sharing-data-1207

Cell and Gene Therapy Report: https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/strengthening-pathways-for-cell-and-gene-therapies

AbbVie and Stemcentrx Acquisition: https://investors.abbvie.com/news-releases/news-release-details/abbvie-expand-oncology-presence-through-acquisition-stemcentrx

Everest Detection: https://everestdetection.com/

Companies, Universities, & People Mentioned:

Goldman Sachs: https://www.goldmansachs.com/

KKR: https://www.kkr.com/

Benchling: https://www.benchling.com/

Stemcentrx: https://investors.abbvie.com/news-releases/news-release-details/abbvie-expand-oncology-presence-through-acquisition-stemcentrx

AbbVie: https://www.abbvie.com/

Everest Detection: https://everestdetection.com/

Timestamps:

00:00 Intro

02:03 KKR, Recruiting, and Long-Term Career Thinking

03:03 Finding Patient Impact in Investing

03:57 The Personal Truth Behind a Career Switch

05:48 Choosing Early-Stage Entrepreneurship

06:33 The Team-and-Market Test

07:46 Digitizing the Lab’s Chaos

08:44 Benchling’s Market Timing

11:58 Luck, Networks, and the Right Wave

13:32 Conviction Behind the Leap

14:34 Learning Leadership at…

Back to The Biotech Startups Podcast · Report a problem